Login to Your Account

Meta Study: Targeted Cancer Drugs Yield Fewer Side Effects

By Nuala Moran
Staff Writer

Wednesday, August 15, 2012
LONDON – A meta-analysis of cancer patients treated in Phase I studies of targeted drugs has confirmed that there is a much lower risk of the most serious side effects than with traditional chemotherapy.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription